Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of 68Ga-NODAGA-SNA006 in Patients With Solid Tumor or Lymphoma

NCT07059832 is registered in ClinicalTrials.gov with First Hospital of China Medical University as lead sponsor.

NCT NCT07059832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07059832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of 68Ga-NODAGA-SNA006 in Patients With Solid Tumor or Lymphoma
Lead sponsor
First Hospital of China Medical University
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
April 1, 2024
Completion date
April 1, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer